personalized therapy
Showing 1 - 25 of >10,000
Hemophilia A Trial in Roma (SenseWear armband device)
Completed
- Hemophilia A
- SenseWear armband device
-
Roma, ItalyFPG
Mar 1, 2023
Atypical Hemolytic Uremic Syndrome Trial in Ranica (Blood sampling and urine analysis)
Not yet recruiting
- Atypical Hemolytic Uremic Syndrome
- Blood sampling and urine analysis
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Mar 28, 2023
Assessment and Implications for Personalized Therapy
Active, not recruiting
- Pancreatic Cancer
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 28, 2022
Parkinson Disease Trial in Worldwide (Adaptive DBS)
Active, not recruiting
- Parkinson Disease
- Adaptive DBS
-
San Francisco, California
- +9 more
Nov 11, 2022
Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Sacituzumab govitecan
- Pembrolizumab
- (no location specified)
Oct 5, 2023
Genomic Sequencing to Find Potential Targets for Personalized
Completed
- Hematologic Neoplasms
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Feb 8, 2022
Patients Suffering From Rare Genodermatoses
Recruiting
- Rare Diseases
- If a targetable cytokine is increased in the lesional skin of a patient, this patient is treated with the respective antibody therapy (off-label use of approved drug).
-
Linz, AustriaKepler University Hospital Linz
Jan 9, 2023
Novel Strategies for Personalized Clinical Decisions in Knee
Completed
- Total Knee Replacement
- Clinical decision support (CDS) tool
-
Greenville, South CarolinaATI Physical Therapy
Jun 9, 2023
Lung Cancer Trial in Palo Alto (Hypofractionated accelerated radiation therapy)
Not yet recruiting
- Lung Cancer
- Hypofractionated accelerated radiation therapy
-
Palo Alto, CaliforniaStanford University
Oct 11, 2023
Anxiety Disorders and Symptoms, Depression, Bipolar Disorder Trial in New York (Personalized MAYA Mobile App, General MAYA
Not yet recruiting
- Anxiety Disorders and Symptoms
- +3 more
- Personalized MAYA Mobile App
- General MAYA Mobile App
-
New York, New YorkWeill Cornell Medical College
Jan 17, 2023
Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended
Not yet recruiting
- Cancer
- +3 more
- 177Lu-PSMA-I&T - escalating renal absorbed dose
- 177Lu-PSMA-I&T - recommended phase 2 regime
- (no location specified)
Jun 14, 2023
Pemphigus, Dermatologic Disease Trial (RiTUXimab Injection)
Not yet recruiting
- Pemphigus
- Dermatologic Disease
- RiTUXimab Injection
- (no location specified)
Jun 7, 2023
Preclinical Research for Personalized TCR-T Therapy for Head and
Recruiting
- Head and Neck Cancer
- No intervention
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Jan 15, 2023
Unmethylated Glioblastoma Trial in Saint Louis (Personalized Neoantigen DNA vaccine, Retifanlimab, TDS-IM v 2.0 electroporation
Not yet recruiting
- Unmethylated Glioblastoma
- Personalized Neoantigen DNA vaccine
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 14, 2023
Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)
Recruiting
- Digestive System Neoplasms
- iNeo-Vac-R01 in combination with standard adjuvant therapy
-
Hangzhou, Zhejiang, ChinaDepartment of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023
Resistant Arterial Hypertension Trial in Ryazan (Blood samples will be taken for pharmacokinetics and pharmacogenetics)
Recruiting
- Resistant Arterial Hypertension
- Blood samples will be taken for pharmacokinetics and pharmacogenetics
-
Ryazan, Russian FederationRyzan State Medical University
Jun 1, 2023
Implementation of Personalized Medicine for Optimal Drug Therapy
Not yet recruiting
- Nausea With Vomiting Chemotherapy-Induced
- +2 more
- Pharmacogenetic testing
- Drug-Drug interaction analysis
-
London, Ontario, CanadaLawson Health Research Institute
Apr 13, 2023
Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)
Recruiting
- Multiple Myeloma in Relapse
- Selinexor
- +4 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 31, 2023
Newly Diagnosed Glioblastoma Trial (combinations of up to 3 FDA approved drugs from a panel of compounds)
Not yet recruiting
- Newly Diagnosed Glioblastoma
- combinations of up to 3 FDA approved drugs from a panel of compounds
- (no location specified)
Jan 19, 2023
Stroke Trial in Geneva (Arm Light Exoskeleton Rehab Station (ALEx RS), Arm Light Exoskeleton Rehab Station (ALEx RS) -
Terminated
- Stroke
- Arm Light Exoskeleton Rehab Station (ALEx RS)
- Arm Light Exoskeleton Rehab Station (ALEx RS) - automatically personalized
-
Geneva, SwitzerlandUniversity Hospital of Geneva
Oct 13, 2022
Thyroid Cancer, Graves Disease Trial in Baltimore (Cervical Collar Therapy Indicator (COTI))
Recruiting
- Thyroid Cancer
- Graves Disease
- Cervical Collar Therapy Indicator (COTI)
-
Baltimore, MarylandJohns Hopkins Hospital
Oct 5, 2022
Molecular Testing for MD Anderson Cancer Center Personalized
Recruiting
- Glioma
- +4 more
- Biospecimen Collection
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)
Recruiting
- Refractory Solid Tumors
- Relapsed Solid Tumors
- KSX01-TCRT cell therapy
-
Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 21, 2023
Neuroblastoma, Cancer Trial in Philadelphia (procedure, genetic, other, behavioral, drug)
Terminated
- Neuroblastoma
- Cancer
- Biopsy
- +12 more
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Jan 31, 2023
Glomerulonephritis, Immunoglobulin A Nephropathy Trial (Corticosteroid, Renin-angiotensin sytem blockers, Sodium-glucose
Not yet recruiting
- Glomerulonephritis
- Immunoglobulin A Nephropathy
- Corticosteroid
- +2 more
- (no location specified)
Oct 13, 2021